R. Gordon Douglas
Robert Gordon Douglas (born April 17, 1934 in New York City ) is an American medical doctor who deals with infectious diseases.
Douglas graduated from Princeton University with a bachelor's degree in 1955 and Cornell University with a doctorate in medicine (MD) in 1959. He completed his residency at New York Hospital (where he was chief resident). From 1963 to 1966 he conducted research at the National Institute of Allergy and Infectious Diseases and in 1966 he became an instructor and later an associate professor at Baylor College and an associate professor in 1970 and professor at the University of Rochester in 1974 . In 1982 he became chief physician at New York Hospital and professor at Cornell University (head of the medical school). In 1990 he went to Merck and in 1991 became head of the vaccine department, which he rebuilt after the company had already considered giving up vaccine development. After he retired from Merck in 1999, he lobbied for the development of a tuberculosis vaccine.
He deals with the pathogenesis of viral diseases of the respiratory tract ( rhinovirus , respiratory syncytial virus ), antiviral chemotherapy (such as amantadine , rimantadine against influenza), vaccinations, influenza, clinical virology and immunoglobulin A.
In 2000 he received the Maxwell Finland Award . He is a member of the National Academies' Institute of Medicine. He was a member of the National Vaccine Advisory Committee and the Children's Vaccine Initiative Consulting Group of the WHO. He is an advisor to the National Institutes of Health's Vaccine Research Center.
He has been married since 1956 and has three children.
Web links
Individual evidence
- ↑ Birth and career data according to American Men and Women of Science , Thomson Gale 2004
| personal data | |
|---|---|
| SURNAME | Douglas, R. Gordon |
| ALTERNATIVE NAMES | Douglas, Robert Gordon (full name) |
| BRIEF DESCRIPTION | American medic |
| DATE OF BIRTH | April 17, 1934 |
| PLACE OF BIRTH | New York City |